Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
PUSH VC is a venture capital firm founded to address pressing challenges in climate change and healthcare. Established in Europe, the firm primarily focuses on Austria and Germany, investing in early-stage startups at the Pre-Seed and Seed stages. The organization aims to support innovative companies that are developing solutions in these vital sectors.
Currently, PUSH VC manages a portfolio of 15 companies, reflecting its commitment to impactful investments. The firm has established itself as a key player in the European venture capital landscape, particularly in the health and green technology sectors. Notable milestones include successful exits such as the acquisition of allcyte by Exscientia in 2021 and careety by haelsi in the same year.
PUSH VC operates from its headquarters in Austria, leveraging local expertise and networks to identify and nurture promising startups. The firm’s limited partner base includes a mix of institutional investors and high-net-worth individuals who share a commitment to sustainability and health innovation.
PUSH VC primarily invests in the health and green technology sectors, with a keen interest in startups that address significant challenges related to climate change and healthcare. The firm’s investment strategy encompasses a diverse range of areas including analytics, circularity, crypto, deep tech, edtech, energy, entertainment, fintech, and HR technology. This broad focus allows PUSH VC to identify innovative solutions across various industries.
The firm targets early-stage companies in Europe, particularly in Austria and Germany, where it believes the potential for growth and impact is substantial. PUSH VC typically invests at the Pre-Seed and Seed stages, providing essential capital and support to help startups develop their products and scale their operations. The organization looks for founders who demonstrate a strong vision, resilience, and a commitment to solving real-world problems.
PUSH VC's portfolio includes a diverse array of companies that reflect its focus on healthcare and climate technology. Notable portfolio companies include:
Laurenz Simbruner, CFA: Founding Partner. Laurenz has extensive experience in venture capital and investment management, having previously worked at notable firms in the industry. He specializes in healthcare investments and has led several successful funding rounds.
Lukas Püspök: Founding Partner. Lukas brings a wealth of knowledge in technology and startup development, with a focus on green technology. His background includes working with various startups across Europe.
Moritz Fiebinger: Venture Partner. Moritz has a strong track record in identifying and supporting early-stage companies, particularly in the biotech and health sectors.
David Aigner: Investment Manager. David is responsible for sourcing and evaluating investment opportunities, with a keen interest in fintech and HR technology.
Magdalena Möslinger-Gehmayr: Operations Manager. Magdalena oversees the operational aspects of the firm, ensuring that portfolio companies receive the necessary support and resources.
To pitch to PUSH VC, founders should visit push.vc and submit their proposals through the provided channels. It is advisable to include a comprehensive deck that outlines the business model, market analysis, and team qualifications. The firm appreciates well-structured pitches that clearly convey the startup's vision and potential.
Response times may vary, but founders can expect feedback within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.
PUSH VC has been actively investing in a diverse range of startups, with a notable portfolio that includes companies like 9am.health and allcyte. The firm emphasizes its commitment to impactful investments in health and green technology. Recent notable exits include the acquisition of allcyte by Exscientia in 2021 and careety by haelsi in the same year. Additionally, Exscientia was acquired by Recursion Pharmaceuticals in 2024, marking a significant milestone for the firm.
As of 2023, PUSH VC continues to expand its portfolio, focusing on innovative startups that align with its investment thesis. The firm remains dedicated to addressing critical challenges in climate change and healthcare through its investments.
What are PUSH VC's investment criteria?
PUSH VC focuses on early-stage startups in the health and green technology sectors, particularly those addressing challenges in climate change and healthcare. The firm invests at the Pre-Seed and Seed stages, looking for innovative solutions and strong founding teams.
How can I pitch to PUSH VC?
Founders can submit their pitches through the firm’s website at push.vc. It is recommended to include a clear business model, market analysis, and details on the team.
What makes PUSH VC different from other investors?
PUSH VC is distinct in its dual focus on healthcare and climate technology, aiming to tackle significant global challenges. The firm emphasizes impactful investments that contribute to sustainability and health innovation.
What is the geographic scope of PUSH VC's investments?
The firm primarily invests in early-stage companies located in Europe, with a strong emphasis on Austria and Germany.
What is the typical check size for investments?
PUSH VC typically invests at the Pre-Seed and Seed stages, with check sizes varying based on the specific needs of the startup and the potential for growth.
What kind of support does PUSH VC provide to portfolio companies?
PUSH VC offers operational support, mentorship, and access to its network of industry experts to help portfolio companies scale and succeed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.